Gao, X., Morales-Barrera, R., Zhang, T., Reimers, M. A., Brown, J. T., Vinceneux, A., Gauna, D. C., Patnaik, A., Matsubara, N., Lebellec, L., Barthélémy, P., Spencer, K. R., Kotecki, N., Gonzalez, A. F., Gedye, C., Sudo, K., Han, H., Aptaker, K., Kelly, T. L., Rosenberg, J. E. (2026). Initial results from EXCEED, a phase 1 study of LY4101174, an antibody-drug conjugate targeting Nectin-4, in participants with advanced or metastatic urothelial carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4517